In a new mice study, researchers showed that beta-amyloid — the toxic protein linked to Alzheimer’s — can gum up the olfactory system and…
With a strong family history of Alzheimer’s, Dewayne Nash had expected that he would start experiencing symptoms of the disease by the time he…
While drug developers are heads down in the lab working to find medical treatments to slow the progression of Alzheimer’s, one tech company is…
From the nature of Alzheimer’s to the solutions available for controlling it, here are five common misconceptions to dispel. Alzheimer’s is the sixth leading…
Early research shows that consistent use of saunas or hot tubs may offer similar health benefits to traditional aerobic exercise — including lowering a…
Scientists still don’t know why some people develop Alzheimer’s and others don’t. But while we may not fully understand the causes of Alzheimer’s, researchers…
Dementia-friendly communities, or age-friendly cities, are defined by the World Health Organization as places where healthcare, socializing and security are adapted to those in…
Since the novel coronavirus began raging across the world last year, scientists have come to understand that patients infected with SARS-CoV-2, the virus responsible…
Two first-of-their-kind studies presented at the Alzheimer’s Association International Conference show transgender and nonbinary adults are more likely show early possible signs of dementia….
In Being Patient’s LiveTalk series, Dr. David Weidman, associate medical director for research at the Banner Alzheimer’s Institute, shares insights on Eli Lilly’s investigational Alzheimer’s…
In the past, scientists have overlooked the vascular system’s role in aging and dementia. But increasingly, research is showing that vascular dysfunction like damage…
Two large hospitals, Cleveland Clinic and Mount Sinai, have decided against administering Aduhelm for patients following controversy around the Alzheimer’s drug’s FDA approval drug…
This article is part of the series Diversity & Dementia, an editorially independent series produced by Being Patient with support provided by Eisai. One day, young Andres…
In the 1990s, the idea that clumps of beta-amyloid proteins are the main culprits of Alzheimer’s took off, and this line of thought —…
UPDATE: 3 March 2024, 8:22 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…